Harbour BioMed Overview
- Founded
- 2016
- Status
- Public
- Employees
- 250
- Stock Symbol
- 02142
- Investments
- 1
- Share Price
- $1.20
- (As of Friday Closing)
Harbour BioMed General Information
Description
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9022, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others.
Contact Information
Website
www.harbourbiomed.com
Formerly Known As
HBM Holdings
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
HKG
Primary Office
- 1 Broadway, 14th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Harbour BioMed Timeline
Harbour BioMed Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.20 | $1.18 | $1.02 - $1.60 | $889M | 741M | 1.72M | -$1.69 |
Harbour BioMed Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 1,284,616 | 1,284,616 | ||
| Revenue | 14,107 | 14,107 | 5,419 | 1,483 |
| EBITDA | (291,736) | (291,736) | (63,552) | (33,385) |
| Net Income | (296,397) | (296,397) | (67,460) | (34,583) |
| Total Assets | 388,738 | 388,738 | 69,499 | 83,499 |
| Total Debt | 1,725 | 1,725 | 1,908 | 3,143 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Harbour BioMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Harbour BioMed‘s full profile, request access.
Request a free trialHarbour BioMed Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiate
Drug Discovery
Cambridge, MA
250
As of 2021
00000
0.000
0000-00-00
00000000
00000
00000000
o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000000
San Diego, CA
000
As of 0000
00000
000000000 -
00000
000 (000
is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
0000 000000000
San Francisco, CA
000
As of 0000
00000
000000 - 000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialHarbour BioMed Competitors (56)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
| 000 (0000000000000 | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | Boston, MA | 0000 | 00.000 | 0000 | 00.000 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
| 000000 00000000000 | Corporation | Plymouth Meeting, PA | 000 | 000.00 | 00000000 | 000.00 |
Harbour BioMed Executive Team (10)
Harbour BioMed Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jingsong Wang MD | Harbour BioMed | Founder, Chief Executive Officer & Chairman | 000 0000 |
Harbour BioMed Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHarbour BioMed Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Harbour BioMed‘s full profile, request access.
Request a free trialHarbour BioMed Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 19-Dec-2016 | 000000000000000000 | Biotechnology | 00000000 0000 00 |
Harbour BioMed Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 0000000000 | Biotechnology | 0000 |